Atomwise develops artificial intelligence systems using powerful deep learning algorithms and supercomputers for drug discovery. Artificial Intelligence Healthcare Pharma

About Atomwise

Atomwise is tracked on 100Xfounder as a startup company, founded in 2012, based in San Francisco Bay Area, California, USA, currently mapped to the Series B stage. Atomwise develops artificial intelligence systems using powerful deep learning algorithms and supercomputers for drug discovery. Artificial Intelligence Healthcare Pharma

Profile snapshot: Founders linked: Atomwise Team. Funding tracked: $175.00M. Hiring focus: Open Roles. Tech tags: AWS, React, Python, and PostgreSQL.

Recent signals:

  • Atomwise appears in the 100Xfounder startup directory import feed.

Why it Matters

Atomwise is worth tracking because its funding history is already mapped here, including a $175.00M round, the hiring signal points to active work across Open Roles roles, recent coverage is already tied back to this page, and Atomwise Team's founder profile is linked directly from the company page. Use this page as the starting point before moving into the company news hub, founder profiles, and related market pages.

Funding Snapshot

Total Funding: $175.00MLast Round: Series B Khosla Ventures, Y Combinator, $175M Series B in 2020All Rounds: 1
  • Series B | Khosla Ventures, Y Combinator, $175M Series B in 2020

Hiring Roles

This company is actively hiring.

Open Roles

Meet the Founders

Tech Stack

AWSReactPythonPostgreSQL

Last updated: May 19, 2026

Atomwise research snapshot

This page is assembled from the published company profile, linked founder directory records, and tagged newsroom context already stored on 100Xfounder. It is most useful as a quick starting point before moving into the deeper company, founder, and hub routes below.

  • Company summary

    Atomwise develops artificial intelligence systems using powerful deep learning algorithms and supercomputers for drug discovery. Artificial Intelligence Healthcare Pharma

  • Founders covered

    Atomwise Team

  • Market position

    Startup | Series B | San Francisco Bay Area, California, USA

  • Newsroom signal

    No direct company-tagged stories are mapped yet; use the connected hubs below for broader market context.

  • Funding signal

    $175.00M

Best next clicks

Start with the lead founder profile if you want operator context first, then return to the company news hub for chronology.

Related Companies

Alternatives in Startup with comparable market signals.

Discover Now

Newsroom and topic pages connected to Atomwise.

No company-specific newsroom stories available yet.

Contextual Research Links

Jump to country, industry, stage, startup taxonomy, and newsroom routes tied to this company.

Want to get featured on 100Xfounder?

Want your company featured with founder details and funding visibility? Start here.

FAQs About Atomwise

Common questions people ask about this profile.

What is Atomwise?

Atomwise develops artificial intelligence systems using powerful deep learning algorithms and supercomputers for drug discovery. Artificial Intelligence Healthcare Pharma

Who founded Atomwise?

Atomwise is associated with Atomwise Team on 100Xfounder.

Where is Atomwise located?

Atomwise is listed in San Francisco Bay Area, California, USA.

What stage is Atomwise in?

Atomwise is currently mapped to Series B. Funding context: Khosla Ventures, Y Combinator, $175M Series B in 2020

What is the latest funding round of Atomwise?

Atomwise's latest tracked round is Series B Khosla Ventures, Y Combinator, $175M Series B in 2020. Total tracked rounds: 1.

Is Atomwise hiring now?

Atomwise hiring status: Open Roles.

What technologies does Atomwise use?

Atomwise is associated with AWS, React, Python, and PostgreSQL.

Is Atomwise verified on 100Xfounder?

Yes. Atomwise is currently marked verified on 100Xfounder as of May 19, 2026.

How can users connect with Atomwise founders?

Users can move from the company page to any linked founder profiles, review the company news hub, and use listed company links when public contact routes are available.